中文
English
한국어
日本語
Español
Français
Русский
| カタログ番号 | HW431107 |
|---|---|
| 説明 |
Anti-Human CD79β/CD79B Antibody (SAA0035) [SAA0035] (HW431107) is a human monoclonal antibody detecting CD79B in FCM. Suitable for Human.
Highlights
|
| 種反応性 | Human |
| アプリケーション | FCM |
| 宿主種 | Human |
| アイソタイプ | IgG1, kappa |
| クローンID | SAA0035 |
| クローン性 | Monoclonal |
| ターゲット | B-cell-specific glycoprotein B29, CD79B, B-cell antigen receptor complex-associated protein beta chain, Ig-beta, B29, Immunoglobulin-associated B29 protein, IGB, CD79b |
| エンドトキシンレベル | Please contact with the lab for this information. |
| 純度 | >95% as determined by SDS-PAGE. |
| 精製 | Protein A/G purified from cell culture supernatant. |
| アクセッション番号 | P40259 |
| 形態 | Liquid |
| 保存バッファー | 0.01M PBS, pH 7.4. データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。 |
| 安定性と保存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| 背景 | B-cell antigen receptor complex-associated protein beta chain (CD79B) is a ~26 kDa protein. Required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Enhances phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. CD79B is the therapeutic target of polatuzumab vedotin (Polivy). |
| 注意事項 | For research use only. |
SDS-PAGE for Anti-Human CD79β/CD79B Antibody (SAA0035)
+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206
